Discovery and Validation of Barrett's Esophagus MicroRNA Transcriptome by Next Generation Sequencing

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Bansal, Ajay ^a,b   Lee, In Hee ^c   Hong, Xiaoman ^d   Mathur, Sharad C ^a,b   Tawfik, Ossama ^b   Rastogi, Amit ^a,b   Buttar, Navtej ^e   Visvanathan, Mahesh ^c   Sharma, Prateek ^a,b   Christenson, Lane K ^b,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c UNIVERSITY OF KANSAS   (United States)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^e MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HSA MICRORNA 1260B; HSA MICRORNA 149 5P; HSA MICRORNA 192 5P; HSA MICRORNA 194 5P; HSA MICRORNA 196A 5P; HSA MICRORNA 203; HSA MICRORNA 205 5P; HSA MICRORNA 215; HSA MICRORNA 224 5P; HSA MICRORNA 3065 5P; HSA MICRORNA 338 3P; HSA MICRORNA 551B 3P; HSA MICRORNA 708 5P; HSA MICRORNA 944; MICRORNA; NOTCH RECEPTOR; TOLL LIKE RECEPTOR; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BARRETT ESOPHAGUS; CELL TRANSFORMATION; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; GASTROESOPHAGEAL REFLUX; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE MAPPING; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MALE; NEXT GENERATION SEQUENCING; PATHOPHYSIOLOGY; PREDICTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; UPREGULATION; VALIDATION STUDY;

AGED; BARRETT ESOPHAGUS; CELL LINE; GASTRIC MUCOSA; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LIBRARY; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MICRORNAS; MIDDLE AGED; RECEPTORS, NOTCH; RNA; SEQUENCE ANALYSIS, RNA; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA;

EID: 84872811505     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054240     Document Type: Article

References (61)

1. Eloubeidi MA, Mason AC, Desmond RA, El-Serag HB, (2003) Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol 98: 1627-1633.
2. Ness-Jensen E, Lindam A, Lagergren J, Hveem K, (2011) Changes in prevalence, incidence and spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-based cohort study, the HUNT study. Gut.
3. Pohl H, Welch HG, (2005) The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97: 142-146.
4. Souza RF, Krishnan K, Spechler SJ, (2008) Acid, bile, and CDX: the ABCs of making Barrett's metaplasia. Am J Physiol Gastrointest Liver Physiol 295: G211-218.
5. Ghildiyal M, Zamore PD, (2009) Small silencing RNAs: an expanding universe. Nat Rev Genet 10: 94-108.
6. Inui M, Martello G, Piccolo S, (2010) MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 11: 252-263.
7. Bansal A, Lee IH, Hong X, Anand V, Mathur SC, et al. (2011) Feasibility of MicroRNAs as Biomarkers for Barrett's Esophagus Progression: A Pilot Cross-Sectional, Phase 2 Biomarker Study. Am J Gastroenterol.
8. Fassan M, Volinia S, Palatini J, Pizzi M, Baffa R, et al. (2010) MicroRNA expression profiling in human Barrett's carcinogenesis. Int J Cancer.
9. Feber A, Xi L, Luketich JD, Pennathur A, Landreneau RJ, et al. (2008) MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg 135: 255-260 discussion 260.
10. Kan T, Sato F, Ito T, Matsumura N, David S, et al. (2009) The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 136: 1689-1700.
11. Leidner RS, Ravi L, Leahy P, Chen Y, Bednarchik B, et al. (2012) The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis. Genes Chromosomes Cancer 51: 473-479.
12. Maru DM, Singh RR, Hannah C, Albarracin CT, Li YX, et al. (2009) MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am J Pathol 174: 1940-1948.
13. Mathe EA, Nguyen GH, Bowman ED, Zhao Y, Budhu A, et al. (2009) MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 15: 6192-6200.
14. Yang H, Gu J, Wang KK, Zhang W, Xing J, et al. (2009) MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma. Clin Cancer Res 15: 5744-5752.
15. Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, et al. (2010) Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327: 198-201.
16. Ozsolak F, Milos PM, (2011) RNA sequencing: advances, challenges and opportunities. Nat Rev Genet 12: 87-98.
17. Kosoff RE, Gardiner KL, Merlo LM, Pavlov K, Rustgi AK, et al. (2012) Development and characterization of an organotypic model of Barrett's esophagus. Journal of cellular physiology 227: 2654-2659.
18. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd, (1997) Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112: 1448-1456.
19. Montgomery E, Bronner MP, Goldblum JR, Greenson JK, Haber MM, et al. (2001) Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 32: 368-378.
20. Metzker ML, (2010) Sequencing technologies- the next generation. Nat Rev Genet 11: 31-46.
21. Langmead B, Trapnell C, Pop M, Salzberg SL, (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
22. Buermans HP, Ariyurek Y, van Ommen G, den Dunnen JT, Hoen PA, (2010) New methods for next generation sequencing based microRNA expression profiling. BMC genomics 11: 716.
23. Joyce CE, Zhou X, Xia J, Ryan C, Thrash B, et al. (2011) Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome. Human molecular genetics 20: 4025-4040.
24. Hackenberg M, Sturm M, Langenberger D, Falcon-Perez JM, Aransay AM, (2009) miRanalyzer: a microRNA detection and analysis tool for next-generation sequencing experiments. Nucleic Acids Res 37: W68-76.
25. Berezikov E, (2011) Evolution of microRNA diversity and regulation in animals. Nature reviews Genetics 12: 846-860.
26. Anders S, Huber W, (2010) Differential expression analysis for sequence count data. Genome Biol 11: R106.
27. Meyer SU, Pfaffl MW, Ulbrich SE, (2010) Normalization strategies for microRNA profiling experiments: a 'normal' way to a hidden layer of complexity? Biotechnol Lett 32: 1777-1788.
28. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B 57: 289-300.
29. Fiedler SD, Carletti MZ, Christenson LK, (2010) Quantitative RT-PCR methods for mature microRNA expression analysis. Methods Mol Biol 630: 49-64.
30. Carletti MZ, Fiedler SD, Christenson LK, (2010) MicroRNA 21 blocks apoptosis in mouse periovulatory granulosa cells. Biol Reprod 83: 286-295.
31. Maragkakis M, Reczko M, Simossis VA, Alexiou P, Papadopoulos GL, et al. (2009) DIANA-microT web server: elucidating microRNA functions through target prediction. Nucleic Acids Res 37: W273-276.
32. Betel D, Wilson M, Gabow A, Marks DS, Sander C, (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res 36: D149-153.
33. Wang X, (2008) miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA 14: 1012-1017.
34. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial microRNA target predictions. Nature genetics 37: 495-500.
35. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E, (2007) The role of site accessibility in microRNA target recognition. Nature genetics 39: 1278-1284.
36. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, et al. (2006) A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126: 1203-1217.
37. Friedman RC, Farh KK, Burge CB, Bartel DP, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome research 19: 92-105.
38. Paquette J, Tokuyasu T, (2010) EGAN: exploratory gene association networks. Bioinformatics 26: 285-286.
39. Jaiswal KR, Morales CP, Feagins LA, Gandia KG, Zhang X, et al. (2007) Characterization of telomerase-immortalized, non-neoplastic, human Barrett's cell line (BAR-T). Diseases of the esophagus: official journal of the International Society for Diseases of the Esophagus/ISDE 20: 256-264.
40. Barrett MT, Pritchard D, Palanca-Wessels C, Anderson J, Reid BJ, et al. (2003) Molecular phenotype of spontaneously arising 4N (G2-tetraploid) intermediates of neoplastic progression in Barrett's esophagus. Cancer Res 63: 4211-4217.
41. Palanca-Wessels MC, Klingelhutz A, Reid BJ, Norwood TH, Opheim KE, et al. (2003) Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model. Carcinogenesis 24: 1183-1190.
42. Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L, et al. (2006) The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 131: 1392-1399.
43. Iorio MV, Croce CM, (2012) microRNA involvement in human cancer. Carcinogenesis.
44. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
45. van Baal JW, Verbeek RE, Bus P, Fassan M, Souza RF, et al. (2012) microRNA-145 in Barrett's oesophagus: regulating BMP4 signalling via GATA6. Gut.
46. Wijnhoven BP, Hussey DJ, Watson DI, Tsykin A, Smith CM, et al. (2010) MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma. Br J Surg 97: 853-861.
47. McKenna LB, Schug J, Vourekas A, McKenna JB, Bramswig NC, et al. (2010) MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function. Gastroenterology 139: 1654-e1651, 1654-1664, 1664, e1651.
48. Milano F, van Baal JW, Buttar NS, Rygiel AM, de Kort F, et al. (2007) Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells. Gastroenterology 132: 2412-2421.
49. Krishnadath KK, (2007) Novel findings in the pathogenesis of esophageal columnar metaplasia or Barrett's esophagus. Curr Opin Gastroenterol 23: 440-445.
50. Souza RF, Freschi G, Taddei A, Ringressi MN, Bechi P, et al. (2011) Barrett's esophagus: genetic and cell changes. Annals of the New York Academy of Sciences 1232: 18-35.
51. di Pietro M, Lao-Sirieix P, Boyle S, Cassidy A, Castillo D, et al. (2012) Evidence for a functional role of epigenetically regulated midcluster HOXB genes in the development of Barrett esophagus. Proc Natl Acad Sci U S A.
52. Shu M, Zhou Y, Zhu W, Zhang H, Wu S, et al. (2011) MiR-335 is Required for Differentiation of Malignant Glioma Cells Induced by Activation of cAMP/PKA Pathway. Molecular pharmacology.
53. Sugatani T, Hruska KA, (2009) Impaired micro-RNA pathways diminish osteoclast differentiation and function. The Journal of biological chemistry 284: 4667-4678.
54. Wang X, Ouyang H, Yamamoto Y, Kumar PA, Wei TS, et al. (2011) Residual embryonic cells as precursors of a Barrett's-like metaplasia. Cell 145: 1023-1035.
55. Kadri SR, Lao-Sirieix P, O'Donovan M, Debiram I, Das M, et al. (2010) Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study. BMJ 341: c4372.
56. Kawaji H, Hayashizaki Y, (2008) Exploration of small RNAs. PLoS Genet 4: e22.
57. Linsen SE, de Wit E, Janssens G, Heater S, Chapman L, et al. (2009) Limitations and possibilities of small RNA digital gene expression profiling. Nat Methods 6: 474-476.
58. Koshiol J, Wang E, Zhao Y, Marincola F, Landi MT, (2010) Strengths and limitations of laboratory procedures for microRNA detection. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 19: 907-911.
59. Lui WO, Pourmand N, Patterson BK, Fire A, (2007) Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 67: 6031-6043.
60. Persson H, Kvist A, Rego N, Staaf J, Vallon-Christersson J, et al. (2011) Identification of new microRNAs in paired normal and tumor breast tissue suggests a dual role for the ERBB2/Her2 gene. Cancer Res 71: 78-86.
61. Reid BJ, Sanchez CA, Blount PL, Levine DS, (1993) Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression. Gastroenterology 105: 119-129.